3-(3,4-dimethoxyphenyl)-5-(3-phenyl-1H-pyrazol-5-yl)-1,2,4-oxadiazole结构式
|
常用名 | 3-(3,4-dimethoxyphenyl)-5-(3-phenyl-1H-pyrazol-5-yl)-1,2,4-oxadiazole | 英文名 | 3-(3,4-dimethoxyphenyl)-5-(3-phenyl-1H-pyrazol-5-yl)-1,2,4-oxadiazole |
|---|---|---|---|---|
| CAS号 | 1107061-66-4 | 分子量 | 348.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H16N4O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 3-(3,4-dimethoxyphenyl)-5-(3-phenyl-1H-pyrazol-5-yl)-1,2,4-oxadiazole |
|---|
| 分子式 | C19H16N4O3 |
|---|---|
| 分子量 | 348.4 |
| InChIKey | MNBMDGRJPMYBRQ-UHFFFAOYSA-N |
| SMILES | COC1=C(C=C(C=C1)C2=NOC(=N2)C3=CC(=NN3)C4=CC=CC=C4)OC |
|
实验名称:Screen for inhibitors of RMI FANCM (MM2) intereaction
来源:11908
靶标:N/A
External Id:RMI-FANCM-MM2
|
|
实验名称:Modulation of AMPAR-stargazin complexes
来源:Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters
靶标:Stargazin (mouse)
External Id:WaveGuideAssay:441
|